Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.

JAMA dermatology - 1 Oct 2018

Wolstencroft Paige W, Casciola-Rosen Livia, Fiorentino David F

Abstract excerpt

Importance: Hydroxychloroquine sulfate is a commonly used medication for patients with dermatomyositis and has been associated with a uniquely elevated risk of adverse cutaneous reactions in this population. No studies to date have examined whether certain subsets of patients with dermatomyositis are at increased risk of experiencing a hydroxychloroquine-associated skin eruption. Objective: To identify disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Autoantibodies
Share to Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Eruptions

Share to Hydroxychloroquine

Share to Interferon-Induced Helicase, IFIH1

Share to Phenotype

Share to Ubiquitin-Activating Enzymes

Source

Open in PubMed Open full text

Identifiers

PMID: 30140893
DOI: 10.1001/jamadermatol.2018.2549
PMCID: PMC6233745

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.PMID 30140893Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesSemantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Anti-SAE Autoantibody-Positive Japanese Patient with Juvenile Dermatomyositis complicated with Interstitial Lung Disease - A Case ReportSemantic proximity Read ↗

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited settingSemantic proximity Read ↗

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon SystemSemantic proximity Read ↗

[The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].Semantic proximity Read ↗

Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.Semantic proximity Read ↗

Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.Semantic proximity Read ↗

Clinical significance of myositis-specific autoantibodiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.